R Bissonnette Selected Research

gusacitinib

10/2019

The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Bissonnette Research Topics

Disease

27	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2023 - 01/2001
9	Atopic Dermatitis (Atopic Eczema) 06/2023 - 04/2012
5	Eczema 02/2022 - 04/2008
4	Actinic Keratosis 06/2012 - 06/2001
3	Pruritus (Itching) 10/2019 - 03/2011
3	Acne Vulgaris 04/2017 - 03/2009
2	Headache (Headaches) 01/2020 - 04/2008
2	Psoriatic Arthritis 09/2018 - 02/2006
2	Necrosis 08/2015 - 06/2015
2	Basal Cell Carcinoma (Rodent Ulcer) 05/2014 - 04/2006
2	Skin Neoplasms (Skin Cancer) 06/2012 - 07/2008
2	Pain (Aches) 12/2011 - 03/2011
1	Dermatitis 06/2023
1	Sleep Deprivation 05/2023
1	Tuberculosis (Tuberculoses) 02/2021
1	Neoplasms (Cancer) 02/2021
1	Venous Thromboembolism 01/2020
1	Nasopharyngitis 01/2020
1	Inflammation (Inflammations) 10/2019
1	Atherosclerosis 10/2019
1	Hyperhidrosis 01/2018
1	Cicatrix (Scar) 04/2017
1	Skin Diseases (Skin Disease) 10/2014
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 05/2014
1	Drug-Related Side Effects and Adverse Reactions 12/2012
1	Melanoma (Melanoma, Malignant) 06/2012
1	Sunburn 07/2008
1	Rheumatoid Arthritis 02/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2001
1	Mycosis Fungoides 01/2001
1	Erythema 11/2000
1	Alopecia Areata 11/2000

Drug/Important Bio-Agent (IBA)

8	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2014 - 11/2000
6	Etanercept (Enbrel)FDA Link 08/2015 - 02/2006
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2002
5	Prostaglandins AIBA 10/2018 - 03/2011
5	AcidsIBA 12/2011 - 11/2000
4	tofacitinibIBA 10/2018 - 01/2013
3	tapinarofIBA 06/2023 - 04/2012
3	secukinumabIBA 09/2018 - 09/2015
3	Monoclonal AntibodiesIBA 09/2018 - 11/2001
3	Janus Kinase InhibitorsIBA 01/2018 - 01/2013
3	Alitretinoin FDA Link 03/2011 - 04/2008
2	baricitinibIBA 02/2021 - 01/2020
2	Janus KinasesIBA 02/2021 - 10/2019
2	Interleukin-23 (Interleukin 23)IBA 01/2019 - 10/2014
2	Interleukin-17 (Interleukin 17)IBA 09/2018 - 10/2014
2	Benzoyl Peroxide FDA LinkGeneric 04/2017 - 03/2009
2	Adalimumab (Humira)FDA Link 08/2015 - 06/2015
2	Infliximab (Remicade)FDA Link 08/2015 - 12/2011
2	Ustekinumab (CNTO 1275)FDA Link 06/2015 - 12/2013
2	Ointments (Pastes)IBA 01/2013 - 01/2002
2	Photosensitizing Agents (Photosensitizers)IBA 12/2011 - 04/2006
2	protoporphyrin IXIBA 04/2006 - 08/2001
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2023
1	Immunoglobulin A (IgA)IBA 02/2022
1	tildrakizumabIBA 01/2020
1	Janus Kinase 1IBA 01/2020
1	Syk KinaseIBA 10/2019
1	gusacitinibIBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	E-SelectinIBA 10/2019
1	mirikizumabIBA 01/2019
1	InterleukinsIBA 01/2019
1	ixekizumabIBA 10/2018
1	apremilastIBA 03/2018
1	GSK573719IBA 01/2018
1	Adapalene (Differin)FDA LinkGeneric 04/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2015
1	Interleukin-12 (IL 12)IBA 06/2015
1	pneumococcal purpura-producing principle (PPPP)IBA 10/2014
1	PorphyrinsIBA 12/2011
1	Hydroxy AcidsIBA 03/2009
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 03/2009
1	Sunscreening Agents (Sunscreens)IBA 07/2008
1	Calcineurin InhibitorsIBA 04/2008
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2008
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2008
1	calcipotriene (calcipotriol)FDA LinkGeneric 01/2002
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 01/2002
1	calcipotriol drug combination betamethasone dipropionate FDA Link 01/2002
1	Aminolevulinic Acid (Levulan)FDA Link 08/2001
1	Triglycerides (Triacylglycerol)IBA 04/2001
1	fibric acidIBA 04/2001

Therapy/Procedure

13	Therapeutics 05/2023 - 04/2008
8	Photochemotherapy (Photodynamic Therapy) 05/2014 - 11/2000
2	Retreatment 01/2015 - 02/2010
1	Phototherapy (Light Therapy) 07/2016
1	Oral Administration 08/2001